Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Promethazine versus ondansetron for acute benign positional vertigo
IRCT20240927063178N1Phase 3Completed
- Sponsor
- Babol University of Medical Sciences
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in benign paroxysmal positional vertigo (BPPV) and Peripheral vertigo comparing Promethazine intramuscular with Ondansetron intravenous (2 arms). Primary endpoints: Vertigo score in questionnaire, Incidence of complications and 1 more. Started Jul 2025; status: completed.
02
Drugs
promethazineondansetron
03
Conditions
benign paroxysmal positional vertigo (BPPV)Peripheral vertigo
Beyond the preview
Go deeper on IRCT20240927063178N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240927063178N1.